Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nektar Therapeutics (NKTR)  
$1.75 0.00 (-0.28%) as of 4:30 Mon 5/20


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 179,400,000
Market Cap: 313.95(M)
Last Volume: 1,560,200 Avg Vol: 2,306,261
52 Week Range: $0.449 - $1.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s research and development pipeline of investigational drugs includes potential therapies for cancer and autoimmune disease. Co.'s proprietary programs include: Immuno-oncology, which involves in developing medicines that target biological pathways which stimulate and sustain the body's immune response in order to fight cancer; and Pain, NKTR-181, a mu-opioid analgesic drug candidate patients with chronic low back pain. Co.'s NKTR-358 is an investigational drug designed to correct the underlying immune system imbalance in the body which occurs in patients with autoimmune disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 92,653 92,653 204,995 510,803
Total Sell Value $124,554 $124,554 $194,453 $1,231,647
Total People Sold 4 4 7 10
Total Sell Transactions 4 4 13 34
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 913
  Page 15 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nicholson John SVP & Chief Operating Officer   •       –      –    2018-05-16 4 S $83.39 $410,029 D/D (4,917) 162,596     -
   Robin Howard W President & CEO   •       •      –    2018-05-16 4 S $83.39 $1,066,641 D/D (12,791) 224,356     -
   Chess Robert Director   –       •      –    2018-05-03 4 AS $82.79 $2,070,050 D/D (25,000) 274,223     -
   Chess Robert Director   –       •      –    2018-05-03 4 OE $5.14 $219,700 D/D 25,000 289,223     -
   Robin Howard W President & CEO   •       •      –    2018-05-03 4 AS $82.86 $3,590,572 D/D (43,333) 237,147     -
   Robin Howard W President & CEO   •       •      –    2018-05-03 4 OE $10.69 $463,230 D/D 43,333 280,480     -
   Labrucherie Gil M SVP & Chief Financial Officer   •       –      –    2018-05-03 4 AS $82.86 $2,485,800 D/D (30,000) 99,739     -
   Labrucherie Gil M SVP & Chief Financial Officer   •       –      –    2018-05-03 4 OE $10.69 $320,700 D/D 30,000 129,739     -
   Robin Howard W President & CEO   •       •      –    2018-05-02 4 AS $85.63 $3,710,605 D/D (43,333) 237,147     -
   Robin Howard W President & CEO   •       •      –    2018-05-02 4 OE $10.69 $463,230 D/D 43,333 280,480     -
   Labrucherie Gil M SVP & Chief Financial Officer   •       –      –    2018-05-02 4 AS $85.63 $2,568,900 D/D (30,000) 99,739     -
   Labrucherie Gil M SVP & Chief Financial Officer   •       –      –    2018-05-02 4 OE $10.69 $320,700 D/D 30,000 129,739     -
   Robin Howard W President & CEO   •       •      –    2018-05-01 4 AS $83.65 $3,624,889 D/D (43,334) 237,147     -
   Robin Howard W President & CEO   •       •      –    2018-05-01 4 OE $10.69 $463,240 D/D 43,334 280,481     -
   Labrucherie Gil M SVP & Chief Financial Officer   •       –      –    2018-05-01 4 AS $83.65 $2,509,500 D/D (30,000) 99,739     -
   Labrucherie Gil M SVP & Chief Financial Officer   •       –      –    2018-05-01 4 OE $10.69 $320,700 D/D 30,000 129,739     -
   Whitfield Roy A Director   –       •      –    2018-04-17 4 OE $14.26 $427,800 D/D 30,000 172,000     -
   Thomsen Jillian B. SVP & Chief Accounting Officer   •       –      –    2018-04-16 4 AS $101.46 $1,408,366 D/D (13,881) 68,857     -
   Thomsen Jillian B. SVP & Chief Accounting Officer   •       –      –    2018-04-16 4 OE $10.69 $148,388 D/D 13,881 82,738     -
   Hora Maninder SVP Pharma Dev & Mfg Ops   •       –      –    2018-04-10 4 AS $105.67 $53,046 D/D (502) 80,261     -
   Hora Maninder SVP Pharma Dev & Mfg Ops   •       –      –    2018-04-10 4 OE $7.21 $3,619 D/D 502 80,763     -
   Hora Maninder SVP Pharma Dev & Mfg Ops   •       –      –    2018-04-09 4 AS $105.05 $997,765 D/D (9,498) 80,261     -
   Hora Maninder SVP Pharma Dev & Mfg Ops   •       –      –    2018-04-09 4 OE $7.21 $68,481 D/D 9,498 89,759     -
   Doberstein Stephen K SVP & Chief Scientific Officer   •       –      –    2018-04-09 4 AS $96.13 $4,758,435 D/D (49,500) 67,394     -
   Doberstein Stephen K SVP & Chief Scientific Officer   •       –      –    2018-04-09 4 OE $7.21 $356,895 D/D 49,500 116,894     -
  913 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us